Search

A recent study conducted by Health Canada examined the relationship between residential radon exposure and two types of lung cancer, small-cell carcinoma and adenocarcinoma, among males and females in Canada. The study found that lung cancer incidence rates correlated with tobacco consumption rates, with females appearing to be more likely than males to develop lung cancer at a given amount of cigarette consumption. Additionally, a statistically significant correlation was observed between radon concentration and lung cancer incidence rates for females, particularly for adenocarcinoma. The study suggests that female non-smokers may be more susceptible to radon-induced lung cancer, and the joint effect of radon exposure and tobacco smoking may be worse in female smokers compared to males. [Extracted from the article]

A patent application titled "A Method To Identify Exceptional Anti-Tumor Benefit From Braf Targeted Therapies" has been published online. The inventor, Hans Ragnar Widlund, proposes a method for determining whether a cancer patient is likely to benefit from treatment with a BRAF inhibitor. The method involves evaluating the presence and level of GAPDHS in a sample of cancer cells and comparing it to a reference level. If the level of GAPDHS is equal to or greater than the reference level, there is a high likelihood of response to the treatment. The patent application also includes methods for treating cancer patients who have been identified as likely to benefit from BRAF inhibitors. The invention aims to personalize precision medicines for improved cancer care. [Extracted from the article]

Researchers at Babol University of Medical Sciences in Iran have published a case report on small cell carcinoma of the uterine cervix (SCCC), a rare and aggressive form of cervical cancer. The report describes the case of a 47-year-old patient with a history of breast cancer who presented with abnormal vaginal bleeding and was diagnosed with SCCC. The patient underwent radical hysterectomy and bilateral salpingo-oophorectomy, followed by adjuvant chemoradiation. The researchers concluded that SCCC has a poor prognosis and that the optimal treatment for this type of cancer is still uncertain. [Extracted from the article]

A new report from the University of Birmingham Medical School discusses a case of small cell lung carcinoma (SCLC) presenting with recurrent pneumothoraces. Pneumothorax is a collection of air in the pleural space, and while it is known to be associated with lung cancer, it is rare for SCLC to present with pneumothorax. The report describes the case of a 62-year-old male patient with a history of COPD and smoking, who presented twice in two months with spontaneous pneumothorax. The patient underwent treatment including surgery and chemotherapy. The prognosis for pneumothorax as a presentation of lung cancer is poor, and the underlying mechanisms are not well understood. [Extracted from the article]

A study conducted at Xinxiang Medical University in Henan, China, aimed to investigate the application value of serum cytokeratin 19 fragment (CYFRA21-1) combined with nerve-specific enolase (NSE), carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCC-Ag) in the diagnosis of lung cancer. The study enrolled 831 cases of lung cancer, 360 cases of benign lung disease, and 102 healthy controls. The results showed that the combined assay of CYFRA21-1, NSE, and CEA could be a potential diagnostic test for lung cancer, addressing accuracy, sensitivity, specificity, and economic cost. The study also found that the expression levels of CYFRA21-1, NSE, and CEA significantly decreased after each treatment course. [Extracted from the article]

A recent preprint abstract from biorxiv.org discusses the role of Kinase Suppressor of Ras 2 (KSR2) in small-cell lung carcinoma (SCLC). The study found that KSR2 promotes the self-renewal and clonogenicity of SCLC cells, particularly in the ASCL1 subtype of SCLC tumors. KSR2 is expressed in pulmonary neuroendocrine cells, which are one of the identified cells of origin for SCLC-A tumors. Disruption of KSR2 inhibits the colony forming ability of tumor propagating cells in vitro and their tumor initiating capacity in vivo. These findings suggest that KSR2 may be a potential therapeutic target for ASCL1-subtype SCLC tumors. However, it is important to note that this preprint has not been peer-reviewed. [Extracted from the article]

A study conducted in Tamil Nadu, India, focused on non-small cell lung cancer (NSCLC) and the use of next-generation sequencing (NGS) to identify targetable driver mutations. The study included 88 patients with metastatic NSCLC and found that the most common mutations were in the endothelial growth factor receptor (EGFR) and echinoderm microtubule-associated protein-like 4 and anaplastic lymphoma kinase (EML4-ALK) genes. The study highlights the importance of NGS in identifying these mutations and suggests the need for further research in this area. [Extracted from the article]

A preprint abstract from biorxiv.org discusses the role of Kinase Suppressor of Ras 2 (KSR2) in small-cell lung carcinoma (SCLC) tumor initiation. The study found that KSR2 promotes the self-renewal and clonogenicity of tumor propagating cells (TPCs) in SCLC. KSR2 is preferentially expressed in the ASCL1 subtype of SCLC tumors and pulmonary neuroendocrine cells. Disruption of KSR2 reduces the colony forming ability of TPCs in vitro and their tumor initiating capacity in vivo. These findings suggest that KSR2 may be a potential therapeutic target for ASCL1 subtype SCLC tumors. However, it is important to note that this preprint has not been peer-reviewed. [Extracted from the article]

Researchers at the University of Ha'il in Saudi Arabia have conducted a study on the potential of plumbagin as an activator of caspase 3 for non-small cell lung carcinoma (NSCLC). Caspase-3 is known to regulate apoptosis, and its deregulation in NSCLC contributes to tumor growth and therapeutic resistance. The study explores the physicochemical and ADMET properties of plumbagin and its potential as a target for drug discovery against caspase-3. The researchers conclude that discovering natural chemicals that act as caspase-3 activators is a crucial step in developing viable drugs for NSCLC. [Extracted from the article]

A report from King Saud University in Riyadh, Saudi Arabia discusses the synthesis and use of a new library of spirooxindole-benzimidazole compounds as inhibitors of the signal transducer and activator of p53, a protein involved in regulating cell growth and cancer prevention. The study evaluates the anti-cancer properties of these compounds, particularly compounds 6a and 6d, and their effects on the growth of breast and prostate carcinoma cells. The research highlights the activation of the p53 pathway by these compounds, leading to upregulation of p53 expression and downregulation of cyclin D and NF-kB in treated cells. The study suggests that compound 6d has potential as a lead compound for further preclinical research. [Extracted from the article]

Researchers from Rutgers University New Jersey Medical School have described seven cases of primary lung tumors with clear cell features and a distinctive FGFR3::TACC3 gene rearrangement. The tumors were found in four women and three men, ranging in age from 47 to 81 years. The tumors showed a solid growth pattern with central areas of necrosis and marked nuclear pleomorphism. Immunohistochemical stains identified a squamous phenotype in five cases and an adenocarcinoma phenotype in two cases. Next-generation sequencing identified FGFR3::TACC3 gene rearrangements in all seven cases. The researchers suggest that identifying this gene rearrangement could be important for potential therapy with tyrosine kinase inhibitors. [Extracted from the article]

This article discusses a case report on the clinical progression of a renal oncocytoma in a 38-year-old female patient who had previously been treated for papillary thyroid cancer. The patient initially had an asymptomatic renal mass that was characterized as a benign oncocytoma. However, over a two-year period, the mass showed increased metabolic activity and slight growth, leading to a reassessment of the diagnosis. Eventually, histopathological analysis confirmed the diagnosis of oncocytoma. The case is notable for the tumor's unusual metabolic evolution and the challenges it posed in differential diagnosis. [Extracted from the article]

A recent study conducted by researchers at the Centre de Recherche in Quebec City, Canada, has found that the localization of CXCL13+ cells within the tumor microenvironment (TME) can predict the response to immune checkpoint inhibitors (ICIs) in patients with advanced non-small cell lung cancer (NSCLC). The study included 65 NSCLC patients treated with Nivolumab/Pembrolizumab, and the researchers found that an increased density of CXCL13+ cells in all compartments of the TME was associated with a poorer prognosis. However, when CXCL13+ cells were colocalized within tertiary lymphoid structures (TLSs), they were associated with a better prognosis. Further validation is needed to confirm the potential relevance of this biomarker in a clinical setting. [Extracted from the article]

A study conducted by Guangxi Medical University in Nanning, China, has found that cyclin-dependent kinase 6 (CDK6) may be a novel biomarker for predicting and prognosing various cancers, including small cell lung carcinoma (SCLC). The study analyzed 111,54 multi-center samples from 34 different cancers and found that CDK6 expression was essential in 24 cancer cell types. Additionally, CDK6 was correlated with immune-related signaling pathways and the infiltration levels of certain immune cells. The research suggests that CDK6 could be used as a biomarker for the prediction and prognosis of several cancers, including SCLC. [Extracted from the article]

A recent report from the Foundation for Research and Technology discusses research findings on non-small cell lung cancer. The study aims to integrate features from different sources, such as imaging, transcriptomics, and clinical data, to predict the survival and therapy response of patients with non-small cell lung cancer. The researchers used machine learning techniques and found significant features for therapy response and survival analysis. The study concludes that multi-omics integration has the potential to improve prediction performance, increase model stability, and reduce bias compared to single-source models. [Extracted from the article]

A new study from the First Department of Internal Medicine discusses a rare case of small cell neuroendocrine carcinoma of the urinary bladder concomitant with antitranscriptional intermediary factor 1-g antibody-positive dermatomyositis. The study describes the case of a 69-year-old Japanese man who presented with elevated creatine kinase levels, haematuria, muscle weakness, and a skin rash. The patient was diagnosed with dermatomyositis and small cell neuroendocrine carcinoma of the urinary bladder. Treatment included glucocorticoid and intravenous immune globulin therapy for dermatomyositis and radiotherapy for the carcinoma. The study highlights the occurrence of antitranscriptional intermediary factor 1-g antibody-positive dermatomyositis with this rare malignancy. [Extracted from the article]

A recent study conducted by researchers at the University of Belgrade in Serbia focuses on personalized medicine and the challenges of multidrug resistance (MDR) in non-small cell lung cancer (NSCLC). The study developed an immunofluorescence-based assay to evaluate MDR markers in NSCLC patient-derived cells. The assay effectively distinguished cancer cells from non-cancer cells and demonstrated the wide-ranging effects of various chemotherapeutic agents on MDR marker expression. The researchers suggest that this assay could complement genetic profiling and optimize treatment, potentially extending its application to other cancer types. [Extracted from the article]

A new study from Hallym University College of Medicine in Seoul, South Korea, explores the application of small cell lung cancer molecular subtyping markers to small cell neuroendocrine carcinoma of the cervix (CSCNEC). CSCNEC is a rare and aggressive type of cervical cancer that shares similarities with small cell lung cancer. The study found that CSCNEC is a heterogeneous disease with different biological phenotypes and that the expression of certain markers, such as NEUROD1, can serve as an independent prognostic factor for worse overall survival. The researchers suggest that tailored treatments based on biomarkers could improve clinical outcomes for patients with CSCNEC. [Extracted from the article]

A recent study conducted by the University of Oklahoma Health Sciences Center examined the impact of nodal staging on overall survival in patients with early-stage non-small cell carcinoma of the lung (NSCLC) who received stereotactic body radiation therapy (SBRT). The study found that there was no difference in mortality risk between patients who underwent nodal staging and those who did not. The study also identified several prognostic factors, such as age, sex, Charlson-Deyo Score, and tumor size, that should be considered when planning therapy for these patients. The findings suggest that nodal staging may not be necessary for all early-stage NSCLC cases treated with SBRT. [Extracted from the article]

A new study conducted by researchers at the Federal Postgraduate Medical Institute in Pakistan examines the frequency and risk factors associated with primary and secondary lung cancers in a sample of the Pakistani population. The study found that lung cancer is one of the most common cancers worldwide, with smoking being a major risk factor. The research analyzed data from 156 patients diagnosed with primary or secondary lung cancers and found that adenocarcinoma was the most frequent type of lung malignancy, followed by squamous cell carcinoma and small cell carcinoma. The study also found a strong association between advancing age, male gender, and cigarette smoking with the diagnosis of lung cancer. [Extracted from the article]

A recent study conducted in Shandong, People's Republic of China, investigated the expression of microRNA-27a-3p (miRNA-27a-3p) in the pulmonary macrophages and peripheral blood of patients with early non-small cell lung carcinoma (NSCLC). The study found that miRNA-27a-3p was downregulated in the pulmonary macrophages and peripheral blood of NSCLC patients, while its target gene CXCL2 was upregulated. The researchers concluded that miRNA-27a-3p may regulate the viability and chemotaxis of macrophages in NSCLC tumor tissues through CXCL2 and could potentially serve as a genetic marker for the disease. This study provides valuable insights into the potential role of miRNA-based therapy in NSCLC treatment. [Extracted from the article]

A patent has been issued for a Chinese medicine composition that can treat side effects caused by BCG perfusion therapy for bladder cancer. The composition is made from a mixture of various plant extracts and is administered to patients experiencing side effects such as red and swollen bladder lining, hematuria, and poor appetite. The patent also mentions that bladder cancer can include various types such as urothelial carcinoma, squamous cell carcinoma, adenocarcinoma, sarcoma, or small cell carcinoma. [Extracted from the article]

Keywords for this news article include: Nanning, People's Republic of China, Asia, Bronchial Neoplasms, Bronchogenic Carcinoma, Cancer, Carcinomas, Health and Medicine, Lung Diseases and Conditions, Lung Neoplasms, Non-Small Cell Lung Cancer, Non-Small-Cell Lung Cancer, Oncology, Respiratory Tract Diseases and Conditions, Respiratory Tract Neoplasms, Small Cell Carcinoma, Small Cell Lung Cancer, Guangxi University of Chinese Medicine. Keywords: Nanning; People's Republic of China; Asia; Bronchial Neoplasms; Bronchogenic Carcinoma; Cancer; Carcinomas; Health and Medicine; Lung Diseases and Conditions; Lung Neoplasms; Non-Small Cell Lung Cancer; Non-Small-Cell Lung Cancer; Oncology; Respiratory Tract Diseases and Conditions; Respiratory Tract Neoplasms; Small Cell Carcinoma; Small Cell Lung Cancer EN Nanning People's Republic of China Asia Bronchial Neoplasms Bronchogenic Carcinoma Cancer Carcinomas Health and Medicine Lung Diseases and Conditions Lung Neoplasms Non-Small Cell Lung Cancer Non-Small-Cell Lung Cancer Oncology Respiratory Tract Diseases and Conditions Respiratory Tract Neoplasms Small Cell Carcinoma Small Cell Lung Cancer 429 429 1 11/06/23 20231107 NES 231107 2023 NOV 7 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Fresh data on Oncology - Small Cell Lung Cancer are presented in a new report. [Extracted from the article]

Keywords: Cancer; Carcinomas; Health and Medicine; Lung Cancer; Lung Diseases and Conditions; Lung Neoplasms; Oncology; Small Cell Carcinoma EN Cancer Carcinomas Health and Medicine Lung Cancer Lung Diseases and Conditions Lung Neoplasms Oncology Small Cell Carcinoma 976 976 1 10/16/23 20231017 NES 231017 2023 OCT 17 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- A new study on lung cancer is now available. For more information on this research see: Synchronous lung cancer presenting with small cell carcinoma and squamous cell lung carcinoma: a case report. [Extracted from the article]

For example, it has been directly demonstrated that the BCR-ABL oncoprotein, a tyrosine kinase fusion protein, is the causative agent in human chronic myelogenous leukemia (CML). The two SLC34A2-ROS fusion proteins are expected to retain ROS tyrosine kinase activity and to drive the proliferation and survival of NSCLC in a subset of such cancers in which the fusion protein is expressed. [Extracted from the article]

For more information on this research see: Liquid biopsy: an innovative and reliable method for detecting not only somatic, but also germline mutations in patients with colorectal and non-small cell lung carcinoma. Keywords: Bronchial Neoplasms; Bronchogenic Carcinoma; Cancer; Carcinomas; Colorectal Research; Gastroenterology; Health and Medicine; Lung Diseases and Conditions; Lung Neoplasms; Non-Small Cell Lung Cancer; Non-Small-Cell Lung Cancer; Oncology; Pharmaceuticals; Pharmacogenetics; Respiratory Tract Diseases and Conditions; Respiratory Tract Neoplasms; Small Cell Carcinoma; Small Cell Lung Cancer EN Bronchial Neoplasms Bronchogenic Carcinoma Cancer Carcinomas Colorectal Research Gastroenterology Health and Medicine Lung Diseases and Conditions Lung Neoplasms Non-Small Cell Lung Cancer Non-Small-Cell Lung Cancer Oncology Pharmaceuticals Pharmacogenetics Respiratory Tract Diseases and Conditions Respiratory Tract Neoplasms Small Cell Carcinoma Small Cell Lung Cancer 562 562 1 09/11/23 20230912 NES 230912 2023 SEP 12 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Fresh data on small cell lung cancer are presented in a new report. [Extracted from the article]

Keywords: Seoul; South Korea; Asia; Bronchial Neoplasms; Bronchogenic Carcinoma; Cancer; Carcinomas; Epidermal Growth Factors; Gastrointestinal Hormones; Genetics; Health and Medicine; Lung Diseases and Conditions; Lung Neoplasms; Non-Small Cell Lung Cancer; Non-Small-Cell Lung Cancer; Oncology; Respiratory Tract Diseases and Conditions; Respiratory Tract Neoplasms; Small Cell Carcinoma; Small Cell Lung Cancer EN Seoul South Korea Asia Bronchial Neoplasms Bronchogenic Carcinoma Cancer Carcinomas Epidermal Growth Factors Gastrointestinal Hormones Genetics Health and Medicine Lung Diseases and Conditions Lung Neoplasms Non-Small Cell Lung Cancer Non-Small-Cell Lung Cancer Oncology Respiratory Tract Diseases and Conditions Respiratory Tract Neoplasms Small Cell Carcinoma Small Cell Lung Cancer 493 493 1 09/11/23 20230912 NES 230912 2023 SEP 12 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Researchers detail new data in Oncology - Small Cell Lung Cancer. Keywords for this news article include: Seoul, South Korea, Asia, Bronchial Neoplasms, Bronchogenic Carcinoma, Cancer, Carcinomas, Epidermal Growth Factors, Gastrointestinal Hormones, Genetics, Health and Medicine, Lung Diseases and Conditions, Lung Neoplasms, Non-Small Cell Lung Cancer, Non-Small-Cell Lung Cancer, Oncology, Respiratory Tract Diseases and Conditions, Respiratory Tract Neoplasms, Small Cell Carcinoma, Small Cell Lung Cancer, Sungkyunkwan University. Seoul, South Korea, Asia, Bronchial Neoplasms, Cancer, Carcinomas, Epidermal Growth Factors, Gastrointestinal Hormones, Genetics, Health and Medicine, Lung Diseases and Conditions, Lung Neoplasms, Non-Small Cell Lung Cancer, Non-Small-Cell Lung Cancer, Oncology, Respiratory Tract Diseases and Conditions, Respiratory Tract Neoplasms, Small Cell Carcinoma, Small Cell Lung Cancer, Bronchogenic Carcinoma. [Extracted from the article]

Keywords: Jiangxi; People's Republic of China; Asia; Cancer; Carcinomas; Health and Medicine; Lung Cancer; Lung Diseases and Conditions; Lung Neoplasms; Neuroendocrine Cancer; Oncology; Risk and Prevention EN Jiangxi People's Republic of China Asia Cancer Carcinomas Health and Medicine Lung Cancer Lung Diseases and Conditions Lung Neoplasms Neuroendocrine Cancer Oncology Risk and Prevention 798 798 1 09/11/23 20230912 NES 230912 2023 SEP 12 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Research findings on Oncology - Neuroendocrine Cancer are discussed in a new report. The news correspondents obtained a quote from the research from Nanchang University, "All SCLC and LCNEC patient data were obtained from the SEER database (2010-2019). [Extracted from the article]

Keywords: Biomarkers; Bronchial Neoplasms; Bronchogenic Carcinoma; Cancer; Carcinomas; Diagnostics and Screening; Health and Medicine; Lung Diseases and Conditions; Lung Neoplasms; Non-Small Cell Lung Cancer; Non-Small-Cell Lung Cancer; Oncology; Respiratory Tract Diseases and Conditions; Respiratory Tract Neoplasms; Small Cell Carcinoma; Small Cell Lung Cancer EN Biomarkers Bronchial Neoplasms Bronchogenic Carcinoma Cancer Carcinomas Diagnostics and Screening Health and Medicine Lung Diseases and Conditions Lung Neoplasms Non-Small Cell Lung Cancer Non-Small-Cell Lung Cancer Oncology Respiratory Tract Diseases and Conditions Respiratory Tract Neoplasms Small Cell Carcinoma Small Cell Lung Cancer 479 479 1 07/24/23 20230725 NES 230725 2023 JUL 25 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Fresh data on small cell lung cancer are presented in a new report. For more information on this research see: USP51 promotes non-small cell lung carcinoma cell stemness by deubiquitinating TWIST1. [Extracted from the article]

For more information on this research see: Expression of MAGE-A3 in and histopathological analysis of forceps biopsy specimens of non- small-cell lung carcinoma patients. Keywords: Adenocarcinoma; Biomarkers; Bronchial Neoplasms; Bronchogenic Carcinoma; Cancer; Carcinomas; Diagnostics and Screening; Health and Medicine; Lung Cancer; Lung Diseases and Conditions; Lung Neoplasms; Oncology; Respiratory Tract Diseases and Conditions; Respiratory Tract Neoplasms; Small Cell Carcinoma; Small Cell Lung Cancer; Software EN Adenocarcinoma Biomarkers Bronchial Neoplasms Bronchogenic Carcinoma Cancer Carcinomas Diagnostics and Screening Health and Medicine Lung Cancer Lung Diseases and Conditions Lung Neoplasms Oncology Respiratory Tract Diseases and Conditions Respiratory Tract Neoplasms Small Cell Carcinoma Small Cell Lung Cancer Software 588 588 1 07/17/23 20230718 NES 230718 2023 JUL 18 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Investigators publish new report on small cell lung cancer. [Extracted from the article]

Keywords: Chongqing; People's Republic of China; Asia; Bronchial Neoplasms; Bronchogenic Carcinoma; Cancer; Carcinomas; Health and Medicine; Lung Diseases and Conditions; Lung Neoplasms; Non-Small Cell Lung Cancer; Non-Small-Cell Lung Cancer; Oncology; Respiratory Tract Diseases and Conditions; Respiratory Tract Neoplasms; Small Cell Carcinoma; Small Cell Lung Cancer EN Chongqing People's Republic of China Asia Bronchial Neoplasms Bronchogenic Carcinoma Cancer Carcinomas Health and Medicine Lung Diseases and Conditions Lung Neoplasms Non-Small Cell Lung Cancer Non-Small-Cell Lung Cancer Oncology Respiratory Tract Diseases and Conditions Respiratory Tract Neoplasms Small Cell Carcinoma Small Cell Lung Cancer 598 598 1 07/17/23 20230718 NES 230718 2023 JUL 18 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Investigators publish new report on Oncology - Small Cell Lung Cancer. Keywords for this news article include: Chongqing, People's Republic of China, Asia, Bronchial Neoplasms, Bronchogenic Carcinoma, Cancer, Carcinomas, Health and Medicine, Lung Diseases and Conditions, Lung Neoplasms, Non-Small Cell Lung Cancer, Non-Small-Cell Lung Cancer, Oncology, Respiratory Tract Diseases and Conditions, Respiratory Tract Neoplasms, Small Cell Carcinoma, Small Cell Lung Cancer, Chongqing University. [Extracted from the article]

Bronchial Neoplasms, Bronchogenic Carcinoma, Cancer, Carcinomas, Health and Medicine, Hemic and Immune Systems, Immunology, Lung Diseases and Conditions, Lung Neoplasms, Lymph Nodes, Lymphoid Tissue, Non-Small Cell Lung Cancer, Oncology, Respiratory Tract Diseases and Conditions, Respiratory Tract Neoplasms, Small Cell Carcinoma, Non-Small-Cell Lung Cancer, Small Cell Lung Cancer Keywords: Bronchial Neoplasms; Bronchogenic Carcinoma; Cancer; Carcinomas; Health and Medicine; Hemic and Immune Systems; Immunology; Lung Diseases and Conditions; Lung Neoplasms; Lymph Nodes; Lymphoid Tissue; Non-Small Cell Lung Cancer; Non-Small-Cell Lung Cancer; Oncology; Respiratory Tract Diseases and Conditions; Respiratory Tract Neoplasms; Small Cell Carcinoma; Small Cell Lung Cancer EN Bronchial Neoplasms Bronchogenic Carcinoma Cancer Carcinomas Health and Medicine Hemic and Immune Systems Immunology Lung Diseases and Conditions Lung Neoplasms Lymph Nodes Lymphoid Tissue Non-Small Cell Lung Cancer Non-Small-Cell Lung Cancer Oncology Respiratory Tract Diseases and Conditions Respiratory Tract Neoplasms Small Cell Carcinoma Small Cell Lung Cancer 536 536 1 07/10/23 20230711 NES 230711 2023 JUL 11 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Current study results on non-small cell lung cancer have been published. [Extracted from the article]

Hubei, People's Republic of China, Asia, Apoptosis, Bronchogenic Carcinoma, Bronchial Neoplasms, Cancer, Carcinomas, Cellular Physiology, Enzymes and Coenzymes, Health and Medicine, Immunology, Luciferases, Lung Diseases and Conditions, Lung Neoplasms, Membrane Proteins, Non-Small Cell Lung Cancer, Non-Small-Cell Lung Cancer, Oncology, Pattern Recognition Receptors, Respiratory Tract Diseases and Conditions, Respiratory Tract Neoplasms, Small Cell Lung Cancer, Small Cell Carcinoma, Toll-Like Receptor 4, Toll-Like Receptors Keywords for this news article include: Hubei, People's Republic of China, Asia, Apoptosis, Bronchial Neoplasms, Bronchogenic Carcinoma, Cancer, Carcinomas, Cellular Physiology, Enzymes and Coenzymes, Health and Medicine, Immunology, Luciferases, Lung Diseases and Conditions, Lung Neoplasms, Membrane Proteins, Non-Small Cell Lung Cancer, Non-Small-Cell Lung Cancer, Oncology, Pattern Recognition Receptors, Respiratory Tract Diseases and Conditions, Respiratory Tract Neoplasms, Small Cell Carcinoma, Small Cell Lung Cancer, Toll-Like Receptor 4, Toll-Like Receptors, Huazhong University of Science and Technology. [Extracted from the article]

The integrative diagnoses included undifferentiated melanoma, cutaneous squamous cell, and basal cell carcinomas, thyroid carcinoma, urothelial carcinoma, hepatocellular carcinoma, pancreatic adenocarcinoma, intrahepatic chol-angiocarcinoma, and synovial sarcoma. Keywords: Boston; State:Massachusetts; United States; North and Central America; Bronchial Neoplasms; Bronchogenic Carcinoma; Cancer; Carcinomas; Diagnostics and Screening; Health and Medicine; Lung Diseases and Conditions; Lung Neoplasms; Non-Small Cell Lung Cancer; Non-Small-Cell Lung Cancer; Oncology; Respiratory Tract Diseases and Conditions; Respiratory Tract Neoplasms; Small Cell Carcinoma; Small Cell Lung Cancer EN Boston State:Massachusetts United States North and Central America Bronchial Neoplasms Bronchogenic Carcinoma Cancer Carcinomas Diagnostics and Screening Health and Medicine Lung Diseases and Conditions Lung Neoplasms Non-Small Cell Lung Cancer Non-Small-Cell Lung Cancer Oncology Respiratory Tract Diseases and Conditions Respiratory Tract Neoplasms Small Cell Carcinoma Small Cell Lung Cancer 650 650 1 05/08/23 20230509 NES 230509 2023 MAY 9 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Data detailed on Oncology - Small Cell Lung Cancer have been presented. [Extracted from the article]

Keywords: Bronchial Neoplasms; Bronchogenic Carcinoma; Cancer; Carcinomas; Chemotherapy; Digestive System Diseases and Conditions; Diverticulitis and Diverticulosis; Drugs and Therapies; Gastroenteritis; Gastrointestinal Diseases and Conditions; Health and Medicine; Lung Diseases and Conditions; Lung Neoplasms; Non-Small Cell Lung Cancer; Non-Small-Cell Lung Cancer; Oncology; Respiratory Tract Diseases and Conditions; Respiratory Tract Neoplasms; Small Cell Carcinoma; Small Cell Lung Cancer; Surgery EN Bronchial Neoplasms Bronchogenic Carcinoma Cancer Carcinomas Chemotherapy Digestive System Diseases and Conditions Diverticulitis and Diverticulosis Drugs and Therapies Gastroenteritis Gastrointestinal Diseases and Conditions Health and Medicine Lung Diseases and Conditions Lung Neoplasms Non-Small Cell Lung Cancer Non-Small-Cell Lung Cancer Oncology Respiratory Tract Diseases and Conditions Respiratory Tract Neoplasms Small Cell Carcinoma Small Cell Lung Cancer Surgery 504 504 1 05/02/23 20230502 NES 230502 2023 MAY 2 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Data detailed on small cell lung cancer have been presented. According to news reporting originating from Tokyo, Japan, by NewsRx correspondents, research stated, "A 71-year-old man was diagnosed with advanced non-small cell lung carcinoma and treated with chemotherapy developed ileocecal diverticulitis three times over the last 2 months of receiving second-line treatment.". [Extracted from the article]

Blood Cells, Cancer, Carcinomas, Granulocytes, Health and Medicine, Hemic and Immune Systems, Immunology, Kidney, Lymphocytes, Mononuclear Leukocytes, Nephrology, Neutrophils, Oncology, Phagocytes Keywords: Blood Cells; Cancer; Carcinomas; Granulocytes; Health and Medicine; Hemic and Immune Systems; Immunology; Kidney; Lymphocytes; Mononuclear Leukocytes; Nephrology; Neutrophils; Oncology; Phagocytes EN Blood Cells Cancer Carcinomas Granulocytes Health and Medicine Hemic and Immune Systems Immunology Kidney Lymphocytes Mononuclear Leukocytes Nephrology Neutrophils Oncology Phagocytes 266 266 1 04/24/23 20230425 NES 230425 2023 APR 25 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- A new study on carcinomas is now available. [Extracted from the article]

Bronchial Neoplasms, Bronchogenic Carcinoma, Cancer, Carcinomas, Health and Medicine, Hospitals, Lung Diseases and Conditions, Lung Neoplasms, Non-Small Cell Lung Cancer, Non-Small-Cell Lung Cancer, Oncology, Pleural Diseases and Conditions, Pleural Effusion, Malignant Pleural Effusion, Respiratory Tract Diseases and Conditions, Respiratory Tract Neoplasms, Small Cell Carcinoma, Small Cell Lung Cancer Keywords: Bronchial Neoplasms; Bronchogenic Carcinoma; Cancer; Carcinomas; Health and Medicine; Hospitals; Lung Diseases and Conditions; Lung Neoplasms; Malignant Pleural Effusion; Non-Small Cell Lung Cancer; Non-Small-Cell Lung Cancer; Oncology; Pleural Diseases and Conditions; Pleural Effusion; Respiratory Tract Diseases and Conditions; Respiratory Tract Neoplasms; Small Cell Carcinoma; Small Cell Lung Cancer EN Bronchial Neoplasms Bronchogenic Carcinoma Cancer Carcinomas Health and Medicine Hospitals Lung Diseases and Conditions Lung Neoplasms Malignant Pleural Effusion Non-Small Cell Lung Cancer Non-Small-Cell Lung Cancer Oncology Pleural Diseases and Conditions Pleural Effusion Respiratory Tract Diseases and Conditions Respiratory Tract Neoplasms Small Cell Carcinoma Small Cell Lung Cancer 334 334 1 03/27/23 20230328 NES 230328 2023 MAR 28 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- A new study on small cell lung cancer is now available. Non-small cell lung carcinoma comprised majority of lung carcinoma cases. [Extracted from the article]

Keywords: Shanghai; People's Republic of China; Asia; Bronchial Neoplasms; Bronchogenic Carcinoma; Cancer; Carcinomas; Health and Medicine; Lung Diseases and Conditions; Lung Neoplasms; Non-Small Cell Lung Cancer; Non-Small-Cell Lung Cancer; Oncology; Respiratory Tract Diseases and Conditions; Respiratory Tract Neoplasms; Small Cell Carcinoma; Small Cell Lung Cancer; Tumor Suppression EN Shanghai People's Republic of China Asia Bronchial Neoplasms Bronchogenic Carcinoma Cancer Carcinomas Health and Medicine Lung Diseases and Conditions Lung Neoplasms Non-Small Cell Lung Cancer Non-Small-Cell Lung Cancer Oncology Respiratory Tract Diseases and Conditions Respiratory Tract Neoplasms Small Cell Carcinoma Small Cell Lung Cancer Tumor Suppression 290 290 1 03/23/23 20230321 NES 230321 2023 MAR 21 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Current study results on Oncology - Non-Small Cell Lung Cancer have been published. Shanghai, People's Republic of China, Asia, Bronchial Neoplasms, Bronchogenic Carcinoma, Cancer, Carcinomas, Health and Medicine, Lung Diseases and Conditions, Lung Neoplasms, Non-Small Cell Lung Cancer, Non-Small-Cell Lung Cancer, Oncology, Respiratory Tract Diseases and Conditions, Respiratory Tract Neoplasms, Small Cell Lung Cancer, Tumor Suppression, Small Cell Carcinoma. [Extracted from the article]

The overall nonsilent mutation rate of uterine cervix SCCs was significantly lower than that of SCLCs, HPV-driven cervical adeno- and squamous cell carcinomas, or HPV-positive head and neck squamous cell carcinomas. Keywords: New York City; State:New York; United States; North and Central America; Cancer; Carcinomas; Genetics; Head and Neck Cancer; Health and Medicine; Human Papillomavirus; Oncology; Small Cell Carcinoma; Squamous Cell Carcinoma EN New York City State:New York United States North and Central America Cancer Carcinomas Genetics Head and Neck Cancer Health and Medicine Human Papillomavirus Oncology Small Cell Carcinoma Squamous Cell Carcinoma 588 588 1 03/23/23 20230321 NES 230321 2023 MAR 21 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- A new study on Oncology - Head and Neck Cancer is now available. [Extracted from the article]

Keywords: Biomedicine; Bone Research; Cancer; Carcinomas; Computed Tomography; Health and Medicine; Imaging Technology; Kidney; Kidney Transplants; Nephrology; Oncology; Organ Transplants; Renal Allograft; Renal Transplant; Surgery; Technology; Transplant Medicine; Transplantation EN Biomedicine Bone Research Cancer Carcinomas Computed Tomography Health and Medicine Imaging Technology Kidney Kidney Transplants Nephrology Oncology Organ Transplants Renal Allograft Renal Transplant Surgery Technology Transplant Medicine Transplantation 291 291 1 03/23/23 20230321 NES 230321 2023 MAR 23 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Current study results on carcinomas have been published. Biomedicine, Bone Research, Cancer, Carcinomas, Computed Tomography, Health and Medicine, Imaging Technology, Kidney, Kidney Transplants, Nephrology, Oncology, Organ Transplants, Renal Allograft, Renal Transplant, Surgery, Technology, Transplant Medicine, Transplantation. [Extracted from the article]

Ehime, Japan, Asia, Adenocarcinoma, Bronchogenic Carcinoma, Bronchial Neoplasms, Cancer, Carcinomas, Health and Medicine, Lung Diseases and Conditions, Lung Neoplasms, Non-Small Cell Lung Cancer, Non-Small-Cell Lung Cancer, Fuzzy Logic, Oncology, Respiratory Tract Diseases and Conditions, Respiratory Tract Neoplasms, Small Cell Carcinoma, Small Cell Lung Cancer, Squamous Cell Carcinoma Keywords: Ehime; Japan; Asia; Adenocarcinoma; Bronchial Neoplasms; Bronchogenic Carcinoma; Cancer; Carcinomas; Fuzzy Logic; Health and Medicine; Lung Diseases and Conditions; Lung Neoplasms; Non-Small Cell Lung Cancer; Non-Small-Cell Lung Cancer; Oncology; Respiratory Tract Diseases and Conditions; Respiratory Tract Neoplasms; Small Cell Carcinoma; Small Cell Lung Cancer; Squamous Cell Carcinoma EN Ehime Japan Asia Adenocarcinoma Bronchial Neoplasms Bronchogenic Carcinoma Cancer Carcinomas Fuzzy Logic Health and Medicine Lung Diseases and Conditions Lung Neoplasms Non-Small Cell Lung Cancer Non-Small-Cell Lung Cancer Oncology Respiratory Tract Diseases and Conditions Respiratory Tract Neoplasms Small Cell Carcinoma Small Cell Lung Cancer Squamous Cell Carcinoma 2023 FEB 14 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Data detailed on Oncology - Small Cell Lung Cancer have been presented. [Extracted from the article]

The news correspondents obtained a quote from the research from Memorial Sloan-Kettering Cancer Center, "We screened 254 SCLC for POU2F3 expression and comprehensively analyzed histopathologic, genomic, and clinical characteristics of POU2F3-positive tumors. This is the largest cohort of SCLC-P clinical samples to date, where we describe the diagnostic utility of POU2F3 in a challenging subset of SCLC with low or absent expression of standard neuroendocrine markers. Keywords: New York City; State:New York; United States; North and Central America; Biomarkers; Cancer; Carcinomas; Diagnostics and Screening; Genetics; Health and Medicine; Oncology EN New York City State:New York United States North and Central America Biomarkers Cancer Carcinomas Diagnostics and Screening Genetics Health and Medicine Oncology 2023 JAN 31 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- A new study on Oncology - Carcinomas is now available. [Extracted from the article]